Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202404745779132Phase 0Recruiting
Phase 0 trial of bupivacaine, sponsored by abdullahi musa olatunji. Started Oct 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202404745779132.